Resoclip

Company Overview

Snapshot

Founded in May 2025, Resoclip operates with 1–10 employees and is currently in the Pre-Funding stage. The company is developing a fully resorbable marker clip for precise soft-tissue localization in imaging-guided procedures.

Business overview

Resoclip is a Health Tech & Life Sciences company specializing in Medical Devices, specifically Assistive Devices. The company develops fully biodegradable, implantable marker clips designed for localizing targeted sites during diagnostic and interventional procedures. Its core technology is based on a proprietary polymer blend, creating a product visible across common imaging modalities such as mammography, ultrasound, CT, and MRI. These markers resorb naturally after a predetermined period, eliminating the need for permanent metallic markers and potential follow-up removal. Resoclip targets use cases including breast and colorectal soft-tissue localization, with future potential in theragnostic applications like local drug delivery.

Company Intelligence Q&A

What is Resoclip's primary product?

Resoclip develops fully biodegradable, implantable marker clips used for accurate soft-tissue localization during diagnostic and interventional procedures.

What is the core technology behind Resoclip's product?

The company's core technology is a proprietary polymer blend that allows its marker clips to be visible across various imaging modalities and then naturally resorb over time.

What markets does Resoclip currently target?

Resoclip targets applications such as breast and colorectal soft-tissue localization, with potential future expansion into theragnostic applications like local drug delivery.

When was Resoclip founded?

Resoclip was founded in May 2025.

In which sector does Resoclip primarily operate?

Resoclip operates within the Health Tech & Life Sciences sector, focusing on Medical Devices and Assistive Devices.